Brief: Neubase Therapeutics Reports Q2 Loss Per Share Of $0.26
14/05/2020 22:08
May 14 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE
SECOND
FISCAL QUARTER OF 2020
* Q2 LOSS PER SHARE $0.26
* Q2 EARNINGS PER SHARE ESTIMATE $-0.22 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX2FqDZx
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet